Abstract Search

ea0041ep117 | Bone & Osteoporosis | ECE2016

Use of Denosumab for treatment of steoporosis at a Tertiary Referral Centre: an evaluation according to the UK National Institute of Health and Care Excellence (NICE) Guidelines

Yahia Seifeldin , Roji A M , Ledda Roberto , Chilaka Chioma , Chokkalingam Kamal , Prinsloo P J , Divyateja H

Aim: To evaluate the use of Denosumab in accordance to the UK National Institute of Health and Care Excellence (NICE) technology appraisal guidelines TA204 Denosumab indicated for the prevention of osteoporotic fractures in post-menopausal women.Methods: A retrospective audit involving 129 patients prescribed Denosumab for osteoporosis between October 2011 and March 2015 at Nottingham University Hospitals, UK. Denosumab prescription data was obtai...

0 shares

ePoster

Endocrine Abstracts

Use of Denosumab for treatment of steoporosis at a Tertiary Referral Centre: an evaluation according to the UK National Institute of Health and Care Excellence (NICE) Guidelines

BiosciAbstracts